Journal
PLANTS-BASEL
Volume 9, Issue 9, Pages -Publisher
MDPI
DOI: 10.3390/plants9091124
Keywords
Eysenhardtia; phytochemical; pharmacological
Categories
Funding
- Consejo Nacional de Ciencia y Tecnologia (CONACYT) [FORDECYT-CIIDZA: 296354]
Ask authors/readers for more resources
The participation of natural products in health care has been remarkable, and today they continue to play a key role in the discovery and development of new treatments. Phytochemical studies together with pharmacological tests have managed to integrate bioactive agents as an alternative solution to reduce or regulate the problems caused by diseases. TheEysenhardtiagenus is a family of plants that are rich in secondary metabolites, which have shown potential activity in the control and mitigation of urinary disorders, diabetes, oxidative stress, protein glycosylation, microbial infections, inflammation, pain or discomfort, muscle contractions, cytotoxicity, or as a cellular or neuronal signaling modulator. These conditions generally appear in comorbid diseases, which motivated the bibliographic review associated with the plant. This document presents the beneficial actions produced byEysenhardtiaextracts and/or bioactives to inhibit, control, or reduce the complications or discomfort of degenerative diseases and thus generate new therapeutic alternatives.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available